US FDA puts Kezar Life Sciences’ lupus treatment trial on hold after patient deaths By Reuters
(Reuters) -The U.S. Food and Drug Administration has placed a clinical hold on Kezar Life Sciences (NASDAQ:)' trial of experimental...
lupus
(Reuters) -The U.S. Food and Drug Administration has placed a clinical hold on Kezar Life Sciences (NASDAQ:)' trial of experimental...
